Chemical Proteomics Reveal CD147 As a Functional Target of Pseudolaric
Total Page：16
File Type：pdf, Size：1020Kb
Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2017 Electronic Supplementary Material (ESI) for Chemical proteomics reveal CD147 as a functional target of pseudolaric acid B in human cancer cells Yiqing Zhou,a Zhengao Di,a Xiaoming Li,bc Yuanhong Shan,d Weichao Li,a Haibing Zhang,b and Youli Xiao*acd aCAS Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China bInstitute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China cUniversity of Chinese Academy of Sciences, Beijing, 100039, China dCore Facility Centre of the Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China 1 Table of Contents 1. Chemistry Pages 3-5 1.1 Synthesis of PAB-Dayne Page 3 Fig. S1 1H-NMR and 13C-NMR data of PAB-Dayne Page 3 1.2 Synthesis of Dead-Dayne Page 4 Fig. S2 1H-NMR and 13C-NMR data of Dead-Dayne Page 5 2. Biological experiments Pages 6-15 2.1 Labeling of purified porcine brain tubulin Page 6 Fig. S3 Dose-dependent labeling of tubulin by PAB-Dayne. Page 6 2.2 Cell proliferation assay Page 6 Table S1 IC50 values of PAB and probes towards HeLa cells. Page 7 2.3 Gel-based AfBPP in HeLa cells Page 7 Fig. S4 Full imaging of gels in Figure 2A. Page 7 2.4 Microscopy Page 7 2.5 Mass spectrometry-based AfBPP in HeLa cells Page 8 2.6 Target validation by pull-down and western blot Page 9 2.7 Labeling of recombinant CD147/CD98 proteins Page 9 2.8 Disruption of CD147 oligomerization by PAB Page 10 2.9 Binding site identification Page 10 Fig. S5 Amino acid sequence of human CD147 isoform 2 Page 11 2.10 Western blot analysis of expression level of MMPs upon PAB treatment Page 11 2.11 siRNA transfection Page 11 2.12 Molecular modeling Page 11 Fig. S6 Ligand interactions and secondary structure of docking Page 12 2.13 Global proteomic profiling of PAB-treated HeLa cells Page 12 Fig. S7 Gene Ontology (GO) biological processes analysis of over- and Page 13 under-expressed proteins of HeLa cells upon PAB treatment Table S2 Top over- and under-expressed proteins upon PAB treatment Page 14 3. Quantitative data of proteomic studies Pages 16-22 Table S3 Proteins identified from the pull-down/LC-MS experiments. Page 16 Table S4 Global proteomic profiling of PAB-treated HeLa cells. Page 22 4. References Page 23 2 1. Chemistry 1.1 PAB-Dayne Scheme S1 Synthesis of PAB-Dayne. Pseudolaric acid B (7.0 mg, 0.016 mmol) was dissolved in anhydrous CH2Cl2 (3.0 mL), and then 1-(3-dimethyl-aminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) (4.8 mg, 0.025 mmol), hydroxyl-benzotriazole (HOBt) (5.5 mg, 0.041 mmol), and N,N-diisopropyl-ethylamine (DIPEA) (6.7 µl, 0.038 mmol) were added into the solution. After 1 hour stirring, 2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethan-1-amine (2.9 mg, 0.021 mmol)[1] was added to the reaction mixture followed by reaction at room temperature for another 3.5 h in the dark. The mixture was washed with saturated Na2CO3, 1N HCl and brine. The organic layer was dried by anhydrous Na2SO4, filtered and concentrated. The crude product was purified by HPLC to provide the desired product PAB-Dayne (7.2 mg, 80.6% yield). 1 H NMR (400 MHz, CDCl3) δ 7.26-7.20 (m, 1H), 6.96 (d, J = 11.4 Hz, 1H), 6.51 (dd, J = 15.0, 11.3 Hz, 1H), 5.83 (d, J = 15.0 Hz, 1H), 3.72 (s, 3H), 3.29 (d, J = 5.4 Hz, 1H), 3.20 (q, J = 6.4 Hz, 2H), 3.08 (dd, J = 14.3, 6.4 Hz, 1H), 2.89 (dd, J = 15.6, 6.3 Hz, 1H), 2.75 (dd, J = 15.1, 8.8 Hz, 1H), 2.64 - 2.58 (m, 1H), 2.19-2.10 (m, 4H), 2.04 (dd, J = 7.2, 2.6 Hz, 2H), 1.99 (s, 3H), 1.85-1.71 (m, 7H), 13 1.66 (t, J = 7.1 Hz, 3H). C NMR (100 MHz, CDCl3) 173.0, 169.4, 168.6, 168.1, 142.5, 141.7, 134.5, 132.8, 130.6, 121.4, 90.1, 83.8, 82.7, 77.2, 69.4, 55.2, 52.1, 49.4, 34.8, 33.3, 32.4, 32.1, 30.7, + 29.7, 28.6, 27.8, 24.3, 21.8, 20.2, 13.2; HRMS-ESI calcd. for C30H38N3O7 [M+H] : 552.2710; Found: 552.2704 3 Fig. S1 1H-NMR and 13C-NMR data of PAB-Dayne. 1.2 Dead-Dayne Scheme S2 Synthesis of Dead-Dayne. To a solution of cyclohexane carboxylic acid (13 mg, 1.2 eq) dissolved in DCM (3.0 mL) in ice bath was added 1-(3-dimethyl -aminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) (20 mg, 1.2 eq), hydroxyl -benzotriazole (HOBt) (14 mg, 1.2 eq), and N,N-diisopropyl-ethylamine (DIPEA) (18 L, 1.2 eq). After stirring for 5 min, 2-(2-azidoethyl)-2-(but-3-ynyl)-1,3-dioxolane (10 mg, 1 eq) was added to the reaction mixture. The resulting solution was warmed to room temperature slowly and stirred for overnight. The reaction mixture was diluted with EtOAc (30 mL), washed with 1 N HCl, saturated NaHCO3, brine, and dried over anhydrous Na2SO4, filtered and concentrated. Purification by flash chromatography column afforded the product Dead-Dayne (16 mg, 90% yield). 1 H NMR (500 MHz, CDCl3) δ 5.55 (s, 1H), 3.11 (q, J = 6.4, 5.8 Hz, 2H), 2.11-1.99 (m, 4H), 1.91-1.77 (m, 4H), 1.72-1.65 (m, 4H), 1.48-1.37 (m, 2H), 1.34-1.27 (m, 4H). 13C NMR (125 MHz, CDCl3) δ 176.08, 82.69, 69.35, 45.52, 34.17, 32.52, 32.19, 29.70, 29.63, 26.91, 25.74, 13.22. + HRMS-ESI calcd. for C14H22N3O [M+H] : 248.1685; Found: 248.1608. 4 Fig. S2 1H-NMR and 13C-NMR data of Dead-Dayne. 5 2. Biological experiments 2.1 Labeling of purified porcine brain tubulin Purified porcine brain tubulin (Cytoskeleton, Inc.) was diluted to a final concentration of 0.1 mg/mL in PBS and incubated with probes as indicated for 30 minutes at room temperature. Samples were transferred to 96-well plate in a same line and irradiated with UV (365 nm, 8 Watt) on ice for 20 minutes. Each of 20 L protein samples were transferred to 0.6 mL tube and added with 1% SDS and fresh prepared 0.25 L each of TAMRA-N3 (10 mM stock in DMSO, Lumiprobe), CuSO4 (100 mM stock in H2O, Sigma), THPTA (Tris(3-hydroxypropyltriazolylmethyl)amine, 10 mM stock in H2O, Sigma) and sodium ascorbate (100 mM stock in H2O). The samples were incubated at room temperature for 1 h and the reaction was quenched by boiling in 5 L of SDS-PAGE loading buffer. 20 L of each sample was applied to SDS-PAGE and detected by FUJIFILM FLA 9000 plus DAGE fluorescence scanner. Finally the gel was visualized by coomassie blue staining. Fig. S3 Dose-dependent labeling of tubulin by PAB-Dayne. 2.2 Cell proliferation assay Human cervical carcinoma HeLa cell line was grown in DMEM (Dulbecco's Modified Eagle Medium, Gibco) supplemented with 1% L-Glutamine, 1% Penicillin-Streptomycin and 10% Fetal Bovine Serum (FBS, Gibco). The culture incubator set is 37 ºC with 5% CO2. HeLa cells cultured for three passages were diluted in respective culture medium to 8000 cells/mL. 100 L of cell suspension were seeded to each well of 96-well plate and incubated at 37 ºC overnight. Various concentrations of compounds (PAB, PAB-Dayne, and Dead-Dayne) were dissolved in culture medium containing 0.5% DMSO. Cells in 96-well plate were treated with 100 µL of various concentrations of compounds and DMSO (negative control) for 48 hours in a 37 ºC incubator. Cell viability was assessed by CellTiter-Glo® Luminescent Kit (Promega). 6 Table S1. IC50 values of PAB and probes towards HeLa cells. Compound IC50 (M) PAB 0.35 ± 0.03 PAB-Dayne 1.17 ± 0.06 Dead-Dayne > 100 2.3 Gel-based affinity-based protein profiling in HeLa cells HeLa cells were grown in culture medium until 90% confluence. The medium was removed and cells were incubated respectively with Dead-Dayne (10 M), PAB-Dayne (10 M), and PAB-Dayne (10 M) with excess PAB (50 M) for 3 hours. The medium was aspirated, and cells were washed three times with ice-cold PBS to remove the excessive probe followed by UV irradiation (365 nm, 8 watt) for 20 min on ice. The cells were harvested by scraping the cells in ice-cold lysis buffer (50 mM HEPES pH 8.0, 150 mM NaCl, 0.1 mM EDTA, 0.1% Triton X-100 and complete protease inhibitors). The lysed cells were centrifuged at 14000 g for 5 minutes and the soluble fractions were diluted to 2 mg/mL with lysis buffer. 1% SDS (w/v) was added to each sample and click reaction was performed as below: for each reaction, 20 L of protein samples were added to freshly prepared 0.25 L each of TAMRA-N3 (10 mM), CuSO4 (100 mM), THPTA (10 mM) and NaVc (100 mM).